Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-β1

被引：8
作者：
Wei, Jia-li
Ma, Chun-yang
Zhang, Yang-De [1 ]
Li, Yiming
机构：
[1] Minist Hlth, Natl Key Lab Nanobiol Technol, Changsha 410008, Peoples R China
[2] Hainan Med Coll, Dept Neurosurg, Affiliated Hosp, Haikou 510008, Hainan, Peoples R China
[3] Kagawa Univ, Fac Med, Dept Cardio Renal & Cerebrovasc Med, Kagawa, Japan
[4] Xi An Jiao Tong Univ, Sch Med, Dept Physiol, Xian 710049, Peoples R China
来源：
CELL BIOLOGY INTERNATIONAL | 2007年 / 31卷 / 05期
关键词：
peroxisome proliferator-activated receptor-gamma agonist; statin; transforming growth factor-beta 1; alpha-smooth muscle actin; connective tissue growth factor; fibronectin; plasminogen activator inhibitor-1; collagen; 1; human renal proximal tubular epithelial cell;
D O I：
10.1016/j.cellbi.2006.11.008
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Recent studies suggest that treatment with PPAR-gamma agonists and statins have beneficial effects on renal disease. However, the combined effects of PPAR-gamma agonists and statins in human renal epithelial cells are unknown. Our present study revealed that there were synergistic effects of pravastatin and pioglitazone in the expression of alpha-smooth muscle actin (alpha-SMA), connective tissue growth factor (CTGF), fibronectin (FN), plasminogen activator inhibitor-1 (PAI-1) and collagen 1 in human renal proximal tubular epithelial cells induced by transforming growth factor-beta 1 (TGF-beta 1). The beneficial effects of combined therapy against renal tubular epithelial cell injury are attributed, at least in part, to the inhibition of transdifferentiation, extracellular matrix deposition and cytokine production. (C) 2006 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：451 / 458
页数：8
相关论文
共 57 条
[1]   Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling [J].
Atfi, A ;
Djelloul, S ;
Chastre, E ;
Davis, RR ;
Gespach, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1429-1432
[2]   Pravastatin up-regulates transforming growth factor-β1 in THP-1 human macrophages:: effect on scavenger receptor class A expression [J].
Baccante, G ;
Mincione, G ;
Di Marcantonio, MC ;
Piccirelli, A ;
Cuccurullo, F ;
Porreca, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 314 (03) :704-710
[3]   Myofibroblast:: A prognostic marker and target cell in progressive renal disease [J].
Badid, C ;
Vincent, M ;
Fouque, D ;
Laville, M ;
Desmoulière, A .
RENAL FAILURE, 2001, 23 (3-4) :543-549
[4]   TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7
[5]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[6]   PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse [J].
Calkin, Anna C. ;
Giunti, Sara ;
Jandeleit-Dahm, Karin A. ;
Allen, Terri J. ;
Cooper, Mark E. ;
Thomas, Merlin C. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) :2399-2405
[7]   Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src [J].
Callera, GE ;
Touyz, RM ;
Tostes, RC ;
Yogi, A ;
He, Y ;
Malkinson, S ;
Schiffrin, EL .
HYPERTENSION, 2005, 45 (04) :773-779
[8]  
Camp HS, 1997, J BIOL CHEM, V272, P10811
[9]  
CHENJ, 2006, AM J PHYSIOL-HEART C, V291, pH1738
[10]   INHIBITION OF CAPILLARY MORPHOGENESIS AND ASSOCIATED APOPTOSIS BY DOMINANT-NEGATIVE MUTANT TRANSFORMING GROWTH-FACTOR-BETA RECEPTORS [J].
CHOI, ME ;
BALLERMANN, BJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) :21144-21150
123456